Long-term safety of dupilumab in patients with moderate-to-severe asthma who completed the liberty asthma traverse continuation study

被引：0
|
作者：
Maspero, J. [1 ]
Peters, A. [2 ]
Chapman, K. [3 ]
Domingo, C. [4 ]
Stewart, J. [5 ]
Hardin, M. [6 ]
Maroni, J. [7 ]
Tawo, K. [8 ]
Khokhar, F. A. [7 ]
Mortenson, E. [7 ]
Laws, E. [8 ]
Amr, R. [7 ]
Jacob-Nara, J. A. [8 ]
Deniz, Y. [7 ]
Rowe, P. J. [8 ]
机构：
[1] Fdn Cidea, Buenos Aires, DF, Argentina
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Autonomous Univ Barcelona, Corporacio Sanitaria Parc Tauli Sabadell, Barcelona, Spain
[5] Sanofi, Montreal, PQ, Canada
[6] Sanofi, Cambridge, MA USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Bridgewater, MA USA
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000186
引用
收藏
页码：188 / 189
页数：2
相关论文
共 50 条
  • [31] Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J.
    Wenzel, S.
    Rabe, K. F.
    Busse, W. W.
    Ford, L.
    Sher, L.
    FitzGerald, J. M.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M. H.
    Hamilton, J. D.
    Swanson, B. N.
    Stahl, N.
    Yancopoulos, G. D.
    Teper, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2486 - 2496
  • [32] Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study
    Wechsler, Michael
    Rogers, Linda
    Canonica, Giorgio
    Bourdin, Arnaud
    Altincatal, Arman
    Hardin, Megan
    Soler, Xavier
    Rowe, Paul
    Deniz, Yamo
    Sacks, Harry
    Jacob-Nara, Juby
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB96 - AB96
  • [33] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [34] DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Castro, M.
    Corren, J.
    Hanania, N.
    Pavord, I.
    Quirce, S.
    Thangavelu, K.
    Rice, M.
    O'Riordan, T.
    Maroni, J.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S8 - S8
  • [35] Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
    Geng, B.
    Busse, W. W.
    Chen, Z.
    Ortiz, B.
    Rowe, P.
    Deniz, Y.
    ALLERGY, 2020, 75 : 17 - 17
  • [36] A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J. F.
    Wenzel, S. E.
    Rabe, K. F.
    Busse, W. W.
    Ford, L. B.
    Sher, L.
    FitzGerald, J.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION
    Hamelmann, E.
    Bacharier, L.
    Maspero, J.
    Katelaris, C.
    Fiocchi, A.
    Gagnon, R.
    De Mir, I
    Guilbert, T.
    Jackson, D.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L.
    Maloney, J.
    Tawo, K.
    Khokhar, F.
    Hardin, M.
    Abdulai, R.
    Lederer, D.
    Robinson, L.
    PNEUMOLOGIE, 2023, 77 : S90 - S91
  • [38] Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION
    Bacharier, L.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A.
    Gagnon, R.
    De Mir-Messa, I
    Guilbert, T. W.
    Jackson, D. J.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L. P.
    Maloney, J.
    Tawo, K.
    Khokhar, F. A.
    Hardin, M.
    Abdulai, R. M.
    Lederer, D. J.
    Robinson, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION
    Leonard, Bacharier B.
    Jorge, Maspero F.
    Constance, Katelaris H.
    Alessandro, Fiocchi G.
    Remi, Gagnon
    Ines, de Mir-Messa
    Theresa, Guilbert W.
    Daniel, Jackson J.
    Eckard, Hamelmann
    Ning, Li
    Bolanle, Akinlade
    Elizabeth, Laws
    Leda, Mannent P.
    Jennifer, Maloney
    Kelsey, Tawo T.
    Faisal, Khokhar A.
    Megan, Hardin
    Raolat, Abdulai M.
    David, Lederer J.
    Lacey, Robinson B.
    KLINISCHE PADIATRIE, 2023, 235 (02): : 110 - 110
  • [40] Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE
    Papi, A.
    Bourdin, A.
    Watz, H.
    Pavord, I. D.
    Domingo, C.
    Wechsler, M. E.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Mannent, L. P.
    Ruddy, M.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345